Fluorine in PDB 7mvs: Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution

Enzymatic activity of Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution

All present enzymatic activity of Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution:
5.6.2.2;

Protein crystallography data

The structure of Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution, PDB code: 7mvs was solved by S.C.Ratigan, C.A.Mcelroy, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 23.74 / 2.60
Space group P 61
Cell size a, b, c (Å), α, β, γ (°) 93.017, 93.017, 406.663, 90, 90, 120
R / Rfree (%) 19.6 / 25.2

Other elements in 7mvs:

The structure of Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution also contains other interesting chemical elements:

Chlorine (Cl) 3 atoms
Manganese (Mn) 2 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution (pdb code 7mvs). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution, PDB code: 7mvs:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 7mvs

Go back to Fluorine Binding Sites List in 7mvs
Fluorine binding site 1 out of 2 in the Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
D:F101

b:57.9
occ:0.60
F01 D:Y1W101 0.0 57.9 0.6
O28 D:Y1W101 0.5 57.9 0.4
C29 D:Y1W101 1.0 73.2 0.4
C02 D:Y1W101 1.4 63.9 0.6
H292 D:Y1W101 1.4 87.8 0.4
H291 D:Y1W101 1.6 87.8 0.4
C27 D:Y1W101 1.6 66.0 0.4
H293 D:Y1W101 1.7 87.8 0.4
H051 D:Y1W101 2.1 87.9 0.6
O05 D:Y1W101 2.3 73.3 0.6
C34 D:Y1W101 2.4 68.1 0.6
C03 D:Y1W101 2.4 69.4 0.6
C26 D:Y1W101 2.5 69.4 0.4
H261 D:Y1W101 2.5 83.3 0.4
H341 D:Y1W101 2.5 81.8 0.6
C30 D:Y1W101 2.7 67.2 0.4
C04 D:Y1W101 2.8 78.8 0.6
H2' D:DG10 2.9 84.5 1.0
H301 D:Y1W101 2.9 80.7 0.4
C5 D:DG10 3.4 53.5 1.0
C8 D:DG10 3.4 67.4 1.0
N7 D:DG10 3.4 50.1 1.0
C4 D:DG10 3.5 58.3 1.0
N9 D:DG10 3.5 69.3 1.0
H061 D:Y1W101 3.5 101.6 0.6
H041 D:Y1W101 3.6 94.6 0.6
N33 D:Y1W101 3.6 60.4 0.6
C25 D:Y1W101 3.7 69.1 0.6
C2' D:DG10 3.7 70.3 1.0
C06 D:Y1W101 3.8 84.7 0.6
C25 D:Y1W101 3.8 68.9 0.4
H8 D:DG10 3.8 81.0 1.0
H5 D:DC11 3.8 89.5 1.0
C5 D:DC11 3.9 74.5 1.0
C31 D:Y1W101 4.0 61.5 0.4
H062 D:Y1W101 4.0 107.5 0.4
H2'' D:DG10 4.0 84.5 1.0
C6 D:DG10 4.1 71.2 1.0
C32 D:Y1W101 4.1 66.0 0.6
N3 D:DG10 4.1 54.6 1.0
C4 D:DC11 4.1 77.9 1.0
C1' D:DG10 4.2 77.2 1.0
H41 D:DC11 4.3 88.8 1.0
H062 D:Y1W101 4.3 101.6 0.6
N4 D:DC11 4.3 74.0 1.0
C6 D:DC11 4.4 86.7 1.0
C32 D:Y1W101 4.4 66.1 0.4
N1 D:DG10 4.6 66.5 1.0
C2 D:DG10 4.6 41.2 1.0
H6 D:DC11 4.6 104.1 1.0
O6 D:DG10 4.7 67.4 1.0
H311 D:Y1W101 4.7 73.8 0.4
N3 D:DC11 4.8 72.3 1.0
H3' D:DG10 4.8 98.7 1.0
O08 D:Y1W101 4.8 93.9 0.6
H42 D:DC11 4.8 88.8 1.0
H232 D:Y1W101 4.8 118.9 0.4
C06 D:Y1W101 4.8 89.5 0.4
C26 D:Y1W101 4.9 67.9 0.6
H1' D:DG10 4.9 92.7 1.0
C03 D:Y1W101 4.9 69.0 0.4
C07 D:Y1W101 4.9 92.5 0.6
C3' D:DG10 4.9 82.2 1.0
H041 D:Y1W101 4.9 96.6 0.4
H261 D:Y1W101 5.0 81.5 0.6
N1 D:DC11 5.0 78.3 1.0

Fluorine binding site 2 out of 2 in 7mvs

Go back to Fluorine Binding Sites List in 7mvs
Fluorine binding site 2 out of 2 in the Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Dna Gyrase Complexed with Uncleaved Dna and Compound 7 to 2.6A Resolution within 5.0Å range:
probe atom residue distance (Å) B Occ
D:F101

b:83.8
occ:0.40
F01 D:Y1W101 0.0 83.8 0.4
O28 D:Y1W101 0.4 85.5 0.6
C29 D:Y1W101 1.3 71.8 0.6
C02 D:Y1W101 1.4 71.8 0.4
C27 D:Y1W101 1.5 70.4 0.6
H292 D:Y1W101 1.6 86.1 0.6
H291 D:Y1W101 1.9 86.1 0.6
H293 D:Y1W101 2.0 86.1 0.6
O05 D:Y1W101 2.1 82.0 0.4
C03 D:Y1W101 2.4 69.0 0.4
C34 D:Y1W101 2.4 70.7 0.4
C26 D:Y1W101 2.4 67.9 0.6
C30 D:Y1W101 2.5 70.2 0.6
H341 D:Y1W101 2.6 84.8 0.4
H261 D:Y1W101 2.6 81.5 0.6
H301 D:Y1W101 2.6 84.2 0.6
C04 D:Y1W101 2.8 80.5 0.4
H051 D:Y1W101 2.8 98.4 0.4
H2' C:DG10 2.9 87.6 1.0
C4 C:DG10 3.2 57.6 1.0
C5 C:DG10 3.3 64.3 1.0
H041 D:Y1W101 3.4 96.6 0.4
N9 C:DG10 3.4 65.1 1.0
N3 C:DG10 3.6 71.4 1.0
N33 D:Y1W101 3.6 69.9 0.4
C2' C:DG10 3.6 73.0 1.0
C25 D:Y1W101 3.6 68.9 0.4
N7 C:DG10 3.7 80.2 1.0
C8 C:DG10 3.7 77.7 1.0
C31 D:Y1W101 3.7 69.5 0.6
H061 D:Y1W101 3.7 107.5 0.4
C25 D:Y1W101 3.7 69.1 0.6
C5 C:DC11 3.7 79.9 1.0
H2'' C:DG10 3.7 87.6 1.0
C06 D:Y1W101 3.8 89.5 0.4
C6 C:DG10 3.9 68.9 1.0
H5 C:DC11 3.9 96.0 1.0
C4 C:DC11 3.9 55.2 1.0
C2 C:DG10 4.0 68.1 1.0
C6 C:DC11 4.0 100.5 1.0
C32 D:Y1W101 4.1 66.1 0.4
C1' C:DG10 4.1 67.4 1.0
N1 C:DG10 4.1 76.1 1.0
H062 D:Y1W101 4.2 101.6 0.6
C32 D:Y1W101 4.2 66.0 0.6
H8 C:DG10 4.2 93.3 1.0
N4 C:DC11 4.3 57.2 1.0
H071 D:Y1W101 4.3 112.4 0.4
N3 C:DC11 4.3 60.5 1.0
H6 C:DC11 4.3 120.7 1.0
H41 C:DC11 4.4 68.7 1.0
N1 C:DC11 4.4 92.6 1.0
H311 D:Y1W101 4.5 83.4 0.6
H062 D:Y1W101 4.6 107.5 0.4
C07 D:Y1W101 4.6 93.6 0.4
C2 C:DC11 4.6 72.2 1.0
O6 C:DG10 4.6 79.5 1.0
H1' C:DG10 4.7 80.9 1.0
H42 C:DC11 4.7 68.7 1.0
H1 C:DG10 4.7 91.4 1.0
O4' C:DC11 4.8 70.2 1.0
H041 D:Y1W101 4.8 94.6 0.6
C26 D:Y1W101 4.8 69.4 0.4
O08 D:Y1W101 4.9 91.9 0.4
C03 D:Y1W101 4.9 69.4 0.6
O24 D:Y1W101 4.9 99.4 0.6
H3' C:DG10 4.9 78.4 1.0
N2 C:DG10 4.9 77.3 1.0
C3' C:DG10 4.9 65.3 1.0
H261 D:Y1W101 4.9 83.3 0.4

Reference:

Y.Lu, S.Vibhute, L.Li, A.Okumu, S.C.Ratigan, S.Nolan, J.L.Papa, C.A.Mann, A.English, A.Chen, J.T.Seffernick, B.Koci, L.R.Duncan, B.Roth, J.E.Cummings, R.A.Slayden, S.Lindert, C.A.Mcelroy, D.J.Wozniak, J.Yalowich, M.J.Mitton-Fry. Optimization of Topoiv Potency, Admet Properties, and Herg Inhibition of 5-Amino-1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of A Lead with in Vivo Efficacy Against Mrsa. J.Med.Chem. 2021.
ISSN: ISSN 0022-2623
PubMed: 34614347
DOI: 10.1021/ACS.JMEDCHEM.1C01250
Page generated: Fri Nov 5 13:13:48 2021

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy